Electrochemical Biosensors for Determination of Colorectal Tumor Biomarkers

ABSTRACT: The accurate determination of specific tumor markers associated with cancer with non-invasive or minimally invasive procedures is the most promising approach to improve the long-term survival of cancer patients and fight against the high incidence and mortality of this disease. Quantificat...

Full description

Autores:
Quinchia Cardona, Jennifer Paola
Echeverri, Danilo
Cruz Pacheco, Andrés Felipe
Maldonado Celis, María Elena
Orozco Holguín, Jahir
Tipo de recurso:
Review article
Fecha de publicación:
2020
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/25332
Acceso en línea:
http://hdl.handle.net/10495/25332
Palabra clave:
Neoplasias Colorrectales
Colorectal Neoplasms
Biomarcadores
Biomarkers
Pruebas en el Punto de Atención
Point-of-Care Testing
Electrochemical Biosensors
Biosensores electroquímicos
In Vitro Diagnostic
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-sa/2.5/co/
Description
Summary:ABSTRACT: The accurate determination of specific tumor markers associated with cancer with non-invasive or minimally invasive procedures is the most promising approach to improve the long-term survival of cancer patients and fight against the high incidence and mortality of this disease. Quantification of biomarkers at different stages of the disease can lead to an appropriate and instantaneous therapeutic action. In this context, the determination of biomarkers by electrochemical biosensors is at the forefront of cancer diagnosis research because of their unique features such as their versatility, fast response, accurate quantification, and amenability for multiplexing and miniaturization. In this review, after briefly discussing the relevant aspects and current challenges in the determination of colorectal tumor markers, it will critically summarize the development of electrochemical biosensors to date to this aim, highlighting the enormous potential of these devices to be incorporated into the clinical practice. Finally, it will focus on the remaining challenges and opportunities to bring electrochemical biosensors to the point-of-care testing.